Abstract
PurposeTo translate and apply the Cataldo Lung Cancer Stigma Scale (CLCSS) for Chinese populations and test the reliability and validity of the modified scale. MethodA total of 150 lung cancer patients were recruited from three tertiary hospitals in Shandong province and were tested using the Chinese version of CLCSS to assess its reliability and validity. ResultThe Cronbach's α coefficient of the Chinese version of CLCSS and the four subscales ranged from 0.599 to 0.884, and the test–retest reliability ranged from 0.601 to 0.881. The content validity index of the scale was 0.875. Four factors were extracted by exploratory factor analysis that explained 58.6% of the total variance. ConclusionThe Chinese version of CLCSS is a reliable and valid measure of stigma among Chinese patients with lung cancer.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
